Repositioning Candidates

Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3

Search for:

     infectious
18 records.
Candidate ID Source ID Source Type Compound Type Candidate Name Inclusion Criteria
R0008 DB00022 approved biotech Peginterferon alfa-2b Therapeutic strategy associated Details
R0017 DB00051 approved; experimental biotech Adalimumab Therapeutic strategy associated Details
R0042 DB00131 approved; investigational; nutraceutical small molecule Adenosine phosphate Target associated Details
R0073 DB00199 approved; investigational; vet_approved small molecule Erythromycin Indication associated Details
R0205 DB00591 approved; investigational; vet_approved small molecule Fluocinolone acetonide Therapeutic strategy associated Details
R0225 DB00635 approved; vet_approved small molecule Prednisone Therapeutic strategy associated Details
R0460 DB01234 approved; investigational; vet_approved small molecule Dexamethasone Therapeutic strategy associated Details
R0488 DB01319 approved small molecule Fosamprenavir Therapeutic strategy associated Details
R0726 DB05186 investigational small molecule SQ-109 Indication associated Details
R0739 DB05212 investigational small molecule HE3286 Therapeutic strategy associated Details
R0811 DB05475 investigational small molecule Golotimod Target associated Details
R0865 DB05767 investigational small molecule Andrographolide Therapeutic strategy associated Details
R1040 DB06532 investigational small molecule Pafuramidine Indication associated Details
R1400 DB11753 approved; investigational small molecule Rifamycin Therapeutic strategy associated Details
R1480 DB13163 approved; experimental small molecule Terpin hydrate Indication associated Details
R1500 DB13908 approved small molecule Amylmetacresol Therapeutic strategy associated Details
R1565 DB15566 approved; vet_approved small molecule Prednisolone acetate Therapeutic strategy associated Details
R1579 DB15746 investigational biotech Recombinant Human Plasma Gelsolin Therapeutic strategy associated Details